Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Probiotics Ingredients Market Insights
3.1. Probiotics ingredients industry snapshot
3.2. Probiotics ingredients value chain & distribution analysis
3.3. Probiotics ingredients market dynamics
3.3.1. Probiotics ingredients Market driver analysis
3.3.2. Probiotics ingredients Market restraint/challenges analysis
3.3.3. Probiotics ingredients Market opportunity analysis
3.4. Industry analysis - Porter's five force
3.5. Probiotics ingredients market PEST analysis, 2018
3.6. Probiotics ingredients industry trends
3.7. Competitive company ranking analysis
4. Probiotics Ingredients Market Size and Forecast, By Ingredients
4.1. Key Findings
4.2. Bacteria
4.2.1. Lactobacillus
4.2.2. Bifidobacterium
4.2.3. Streptococcus and Enterococcus
4.3. Yeast
4.3.1. Saccharomyces Cerevisiae
4.3.2. Saccharomyces Boulardi
4.3.3. Coli
4.4. Spore Formers
5. Probiotics Ingredients Market Size and Forecast, By Application
5.1. Key Findings
5.2. Probiotic Food & Beverages
5.3. Probiotic Dietary Supplements
5.4. Animal Feed Probiotics
5.5. Others
6. Probiotics Ingredients Market Size and Forecast, By End-use
6.1. Key Findings
6.2. Human Probiotics
6.3. Animal Probiotic
7. Probiotics Ingredients Market Size and Forecast by Regions
7.1. Key findings
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. UK
7.3.3. France
7.4. Asia Pacific
7.4.1. China
7.4.2. India
7.4.3. Japan
7.5. Latin America
7.5.1. Brazil
7.5.2. Mexico
7.6. Middle East & Africa
8. Company Profiles
8.1. Probiotical S.p.A.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Benchmarking
8.1.4. Recent Developments
8.2. Sabinsa Corporation
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Benchmarking
8.2.4. Recent Developments
8.3. Ganeden Inc.
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Benchmarking
8.3.4. Recent Developments
8.4. BioGaia AB.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Benchmarking
8.4.4. Recent Developments
8.5. Biocodex, Inc.
8.5.1. Overview
8.5.2. Financials
8.5.3. Product Benchmarking
8.5.4. Recent Developments
8.6. AB Biotics
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Benchmarking
8.6.4. Recent Developments
8.7. Probiotical SpA
8.7.1. Overview
8.7.2. Financials
8.7.3. Product Benchmarking
8.7.4. Recent Developments
8.8. ProbioFerm
8.8.1. Overview
8.8.2. Financials
8.8.3. Product Benchmarking
8.8.4. Recent Developments
8.9. Lallemand
8.9.1. Overview
8.9.2. Financials
8.9.3. Product Benchmarking
8.9.4. Recent Developments
8.10. Protexin
8.10.1. Overview
8.10.2. Financials
8.10.3. Product Benchmarking
8.10.4. Recent Developments